0001053310-18-000001.txt : 20181219
0001053310-18-000001.hdr.sgml : 20181219
20181219184532
ACCESSION NUMBER: 0001053310-18-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181219
FILED AS OF DATE: 20181219
DATE AS OF CHANGE: 20181219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAY E GERALD
CENTRAL INDEX KEY: 0001053310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31668
FILM NUMBER: 181244385
MAIL ADDRESS:
STREET 1: C/O 225 LONG AVENUE
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC
CENTRAL INDEX KEY: 0001016504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222407475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
BUSINESS PHONE: 9739260816
MAIL ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC
DATE OF NAME CHANGE: 20020912
FORMER COMPANY:
FORMER CONFORMED NAME: CHEM INTERNATIONAL INC
DATE OF NAME CHANGE: 19960716
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-12-19
0
0001016504
INTEGRATED BIOPHARMA INC
inbp.ob
0001053310
KAY E GERALD
C/O 225 LONG AVENUE
HILLSIDE
NJ
07205
1
1
1
0
Chief Executive Officer
Common Stock
2018-12-19
2018-12-19
4
A
0
100000
0.1
A
5262556
D
100,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
/S/ E Gerald Kay
2018-12-19